France Metagenomics Market Size, Share, and COVID-19 Impact Analysis, By Technology (Shotgun Sequencing, Whole Genome Sequencing), By Product (Kits & Reagents, Sequencing & Data Analytics Services and Software), and France Metagenomics Market Insights, Industry Trend, Forecasts to 2035.

Industry: Healthcare

RELEASE DATE Jun 2025
REPORT ID SI12810
PAGES 230
REPORT FORMAT PathSoft

France Metagenomics Market Insights Forecasts to 2035 

  • The France Metagenomics Market Size was estimated at USD 84.2 Million in 2024
  • The Market Size is Expected to Grow at a CAGR of around 13.00% from 2025 to 2035
  • The France Metagenomics Market Size is Expected to Reach USD 323.1 Million by 2035

Get more details on this report -

Request Free Sample PDF

According to a research report published by Spherical Insights & Consulting, The France Metagenomics Market Size is anticipated to reach USD 323.1 Million by 2035, growing at a CAGR of 13.00% from 2025 to 2035. This is because the main driver of this market's expansion is the falling cost of sequencing. Drop-Seq and other cutting-edge technologies have become powerful whole-genome sequencing tools that make it possible to analyse many cells at a reasonable cost.

 

Market Overview 

The France metagenomics market is concerned with studying genetic constituents obtained directly from environmental samples, allowing researchers to study microbial communities without isolating and culturing individual microbes. In essence, it involves studying the genomes of all microbes from any environment. This field of study has changed the way we think about microbial diversity and function, and their roles in many ecosystems, including the human body. The decreasing cost of sequencing is expected to increase the use of metagenomics across various activities. As a result, numerous genome-related programs have been launched at the national level in the last few years. Initiatives taken strategically by universities and companies to pursue these new technologies are expected to contribute to market growth. The first driver of growth in this market is reducing sequencing costs. The adoption of new technologies, such as Drop-Seq, is generating new possibilities for whole-genome sequencing and challenging the assumption that sequencing costs always reflect the sequencing of a fixed number of cells, making it economical to analyze many cells. 

 

Report Coverage

This research report categorizes the market for the France metagenomics market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France metagenomics market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France metagenomics market. 

 

France Metagenomics Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 84.2 Million
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :13.00%
2035 Value Projection:USD 323.1 Million
Historical Data for:2020-2023
No. of Pages:230
Tables, Charts & Figures:110
Segments covered:By Technology, By Product
Companies covered:: Bio-Rad Laboratories, Inc, Illumina, Inc., Takara Bio, Inc., Novogene Co., Ltd., Oxford Nanopore Technologies, QIAGEN, Thermo Fisher Scientific, Inc., Promega Corporation, and Others
Pitfalls & Challenges:COVID-19 Impact, Challenges, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The France metagenomics market is driven by the burgeoning number of patents for systems & methods for metagenomics reflects this growing interest and innovation in the area. Further adoption will likely also be stimulated by the development of biotech tools that enable laboratory workflows to be streamlined. Developments in bioinformatics relate to a clearer market strategy to offer better verification & data analysis capabilities, which are expected to help spur the French market growth.

 

Restraining Factors

There are a number of challenges in the France metagenomics market, including sample collection, DNA extraction, and data analysis, and common standards for different types of research environments. Another major impediment includes costly metagenomic sequencing, which is accompanied by the need for experts trained in the field.

 

Market Segmentation

The France metagenomics market share is classified into technology and product.

 

  • The shotgun sequencing segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France metagenomics market is segmented by technology into shotgun sequencing, whole genome sequencing. Among these, the shotgun sequencing segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. By randomly dividing DNA into tiny pieces and sequencing each one, shotgun sequencing can sequence entire genomes.  It is widely used in clinical diagnostics, genomics research, and a number of other industries, including agriculture and crop improvement, environmental monitoring, and conservation.

 

  • The kits & reagents segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France metagenomics market is segmented by product into kits & reagents, sequencing & data analytics services, and software. Among these, the kits & reagents segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. Reagents and kits are made for particular uses, like the analysis of biological, water, and soil samples.  Depending on the needs of the study, these are frequently used to screen for bacteria, viruses, pathogens, fungi, and micro-eukaryotic species.  

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France metagenomics market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

 

List of Key Companies

  • Bio-Rad Laboratories, Inc
  • Illumina, Inc.
  • Takara Bio, Inc.
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies
  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Promega Corporation
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France Metagenomics Market based on the below-mentioned segments:

 

France Metagenomics Market, By Technology                                                    

  • Shotgun Sequencing
  • Whole Genome Sequencing

 

France Metagenomics Market, By Product                                                        

  • Kits & Reagents
  • Sequencing & Data Analytics Services
  • Software

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies